Andrea Sboner
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 33
- Cancer, Lipids, and Metabolism 10
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 54
- Prostate Cancer Diagnosis and Treatment 15
- Oncology top 2%
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 9
- Ubiquitin and proteasome pathways 8
-
- Radiopharmaceutical Chemistry and Applications 12
-
- Genomics and Rare Diseases 8
- Co-authors
- Mark A. RubinMark GersteinHimisha BeltranOlivier ElementoFrancesca DemichelisJuan Miguel MosqueraDavid M. NanusScott T. Tagawa
- Partner nations
- United StatesIsraelItaly
In The Last Decade
Andrea Sboner
133 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 3.0k
- Oncology 1.6k
- Molecular Biology 3.5k
- Pathology and Forensic Medicine 448
Countries citing papers authored by Andrea Sboner
This map shows the geographic impact of Andrea Sboner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Sboner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Sboner more than expected).
Fields of papers citing papers by Andrea Sboner
This network shows the impact of papers produced by Andrea Sboner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Sboner. The network helps show where Andrea Sboner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea Sboner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 20 | |
| 14 | 2021 | 50 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 27 | |
| 17 | Clinical features of neuroendocrine prostate cancerbreakdown → | 2019 | 232 |
| 18 | 2017 | 52 | |
| 19 | 2016 | 67 | |
| 20 | 2007 | 60 |
About Andrea Sboner
Andrea Sboner is a scholar working on Cancer Research, Health Informatics and Pulmonary and Respiratory Medicine, having authored 139 papers that have together received 6.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (54 papers), Cancer Genomics and Diagnostics (33 papers), Prostate Cancer Diagnosis and Treatment (15 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Cancer, Lipids, and Metabolism (10 papers), Epigenetics and DNA Methylation (9 papers), Genomics and Rare Diseases (8 papers) and Ubiquitin and proteasome pathways (8 papers). The work is most often cited by research in Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (3.0k citations) and Oncology (1.6k citations). Andrea Sboner has collaborated with scholars based in United States, Israel and Italy. Frequent co-authors include Mark A. Rubin, Mark Gerstein, Himisha Beltran, Olivier Elemento, Francesca Demichelis, Juan Miguel Mosquera, David M. Nanus, Scott T. Tagawa, Davide Prandi and Rohan Bareja. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.